Comparison of standard versus double dose of amoxicillin in the treatment of non‐severe pneumonia in children aged 2–59 months: a multi‐centre, double blind, randomised controlled trial in Pakistan

Similar Items

• Assessment and management of children aged 1–59 months presenting with wheeze, fast breathing, and/or lower chest indrawing; results of a multicentre descriptive study in Pakistan
  od: Hazir, T, i dr.
  Izdano: (2004)
• Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan
  od: Hazir, Tabish, i dr.
  Izdano: (2006)
• Randomized trial of amoxicillin vs. placebo for pneumonia in Pakistan: A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
  od: Jehan, Fyezah, i dr.
  Izdano: (2020)
• Low Rates of Treatment Failure in Children Aged 2–59 Months Treated for Severe Pneumonia: A Multisite Pooled Analysis
  od: Fox, Matthew P., i dr.
  Izdano: (2013)
• A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
  od: Jehan, Fyezah, i dr.
  Izdano: (2016)